Spyre Therapeutics (SYRE) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Spyre Therapeutics (SYRE) over the last 11 years, with Q3 2025 value amounting to $5.4 million.
- Spyre Therapeutics' Interest & Investment Income rose 376.16% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year increase of 1963.18%. This contributed to the annual value of $21.3 million for FY2024, which is 24670.57% up from last year.
- Spyre Therapeutics' Interest & Investment Income amounted to $5.4 million in Q3 2025, which was up 376.16% from $5.9 million recorded in Q2 2025.
- In the past 5 years, Spyre Therapeutics' Interest & Investment Income ranged from a high of $6.5 million in Q1 2025 and a low of $19000.0 during Q2 2021
- In the last 5 years, Spyre Therapeutics' Interest & Investment Income had a median value of $420000.0 in 2023 and averaged $2.4 million.
- As far as peak fluctuations go, Spyre Therapeutics' Interest & Investment Income plummeted by 8819.88% in 2021, and later skyrocketed by 159142.86% in 2024.
- Over the past 5 years, Spyre Therapeutics' Interest & Investment Income (Quarter) stood at $34000.0 in 2021, then soared by 1105.88% to $410000.0 in 2022, then surged by 906.34% to $4.1 million in 2023, then skyrocketed by 39.99% to $5.8 million in 2024, then dropped by 6.87% to $5.4 million in 2025.
- Its Interest & Investment Income stands at $5.4 million for Q3 2025, versus $5.9 million for Q2 2025 and $6.5 million for Q1 2025.